XML 16 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
COMMON STOCK
TREASURY STOCK
ADDITIONAL PAID-IN CAPITAL
ACCUMULATED DEFICIT
Beginning balance (in shares) at Dec. 31, 2024   40,554,705      
Beginning balance at Dec. 31, 2024 $ 571,553 $ 4 $ 0 $ 1,140,328 $ (568,779)
Beginning balance (in shares) at Dec. 31, 2024     0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   7,342      
Exercise of common stock options 4     4  
Stock-based compensation 8,863     8,863  
Net income (loss) 148,451       148,451
Ending balance (in shares) at Mar. 31, 2025   40,562,047      
Ending balance at Mar. 31, 2025 728,871 $ 4 $ 0 1,149,195 (420,328)
Ending balance (in shares) at Mar. 31, 2025     0    
Beginning balance (in shares) at Dec. 31, 2024   40,554,705      
Beginning balance at Dec. 31, 2024 571,553 $ 4 $ 0 1,140,328 (568,779)
Beginning balance (in shares) at Dec. 31, 2024     0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 117,755        
Ending balance (in shares) at Jun. 30, 2025   40,615,414      
Ending balance at Jun. 30, 2025 706,734 $ 4 $ 0 1,157,754 (451,024)
Ending balance (in shares) at Jun. 30, 2025     0    
Beginning balance (in shares) at Mar. 31, 2025   40,562,047      
Beginning balance at Mar. 31, 2025 728,871 $ 4 $ 0 1,149,195 (420,328)
Beginning balance (in shares) at Mar. 31, 2025     0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   53,367      
Exercise of common stock options 17     17  
Stock-based compensation 8,542     8,542  
Net income (loss) (30,696)       (30,696)
Ending balance (in shares) at Jun. 30, 2025   40,615,414      
Ending balance at Jun. 30, 2025 706,734 $ 4 $ 0 1,157,754 (451,024)
Ending balance (in shares) at Jun. 30, 2025     0    
Beginning balance (in shares) at Dec. 31, 2025   40,670,466      
Beginning balance at Dec. 31, 2025 $ 303,132 $ 4 $ (384,558) 1,169,451 (481,765)
Beginning balance (in shares) at Dec. 31, 2025 (21,126,760)   (21,126,760)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   15,304      
Exercise of common stock options $ 7     7  
Vesting of restricted stock (in shares)   173,827      
Stock-based compensation 6,199     6,199  
Net income (loss) (23,708)       (23,708)
Ending balance (in shares) at Mar. 31, 2026   40,859,597      
Ending balance at Mar. 31, 2026 285,630 $ 4 $ (384,558) 1,175,657 (505,473)
Ending balance (in shares) at Mar. 31, 2026     (21,126,760)    
Beginning balance (in shares) at Dec. 31, 2025   40,670,466      
Beginning balance at Dec. 31, 2025 $ 303,132 $ 4 $ (384,558) 1,169,451 (481,765)
Beginning balance (in shares) at Dec. 31, 2025 (21,126,760)   (21,126,760)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares) 82,304        
Net income (loss) $ (52,418)        
Ending balance (in shares) at Jun. 30, 2026   40,953,948      
Ending balance at Jun. 30, 2026 $ 262,320 $ 4 $ (384,558) 1,181,057 (534,183)
Ending balance (in shares) at Jun. 30, 2026 (21,126,760)   (21,126,760)    
Beginning balance (in shares) at Mar. 31, 2026   40,859,597      
Beginning balance at Mar. 31, 2026 $ 285,630 $ 4 $ (384,558) 1,175,657 (505,473)
Beginning balance (in shares) at Mar. 31, 2026     (21,126,760)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   67,000      
Exercise of common stock options 23     23  
Vesting of restricted stock (in shares)   27,351      
Stock-based compensation 5,377     5,377  
Net income (loss) (28,710)       (28,710)
Ending balance (in shares) at Jun. 30, 2026   40,953,948      
Ending balance at Jun. 30, 2026 $ 262,320 $ 4 $ (384,558) $ 1,181,057 $ (534,183)
Ending balance (in shares) at Jun. 30, 2026 (21,126,760)   (21,126,760)